Pfizer may make counter bid for Ranbaxy: report
MUMBAI (Reuters) - Pfizer Inc may bid for Ranbaxy Laboratories Ltd, countering a $4.6 billion offer by Japan's Daiichi Sankyo Co Ltd for the Indian generic drug maker, the Business Standard newspaper said. 5 months ago
Reuters Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook